Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

TY - JOUR

T1 - Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

AU - on behalf of the

AU - 21st WHO Expert Committee on Selection and Use of Essential Medicines

AU - Sharland, Mike

AU - Pulcini, Celine

AU - Harbarth, Stephan

AU - Zeng, Mei

AU - Gandra, Sumanth

AU - Mathur, Shrey

AU - Magrini, Nicola

N1 - Funding Information: MS reports grants from GlaxoSmithKline, Pfizer, Cubist Pharmaceuticals, and the Drugs for Neglected Diseases Initiative outside the submitted work. CP reports a grant from the Innovative Medicines Initiative and personal fees from Pfizer outside the submitted work. SH reports grants from the Innovative Medicines Initiative, Pfizer, and BioMérieux outside the submitted work; and reports personal fees from Novartis, GlaxoSmithKline, Debiopharm, and Janssen outside the submitted work. All other authors declare no competing interests.

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85040659430&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(17)30724-7

DO - 10.1016/S1473-3099(17)30724-7

M3 - Comment/debate

C2 - 29303731

AN - SCOPUS:85040659430

VL - 18

SP - 18

EP - 20

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 1

ER -